Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01218
|
|||||
| Drug Name |
Mycophenolic acid
|
|||||
| Synonyms |
(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid; 6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid; Acide mycophenolique; Acido micofenolico; Acido micofenolico [INN-Spanish]; Acidum mycophenolicum; CCRIS 5565; Lilly-68618; Ly 68618; Melbex; Micofenolico acido; Micofenolico acido [Spanish]; Mycophenoic acid; Mycophenolate; Mycophenolsaeure; Myfortic; NSC 129185; NSC-129185; UNII-HU9DX48N0T; mycophenolic acid
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Organ transplant rejection [ICD11: NE84] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H20O6
|
|||||
| Canonical SMILES |
CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O
|
|||||
| InChI |
InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+
|
|||||
| InChIKey |
HPNSFSBZBAHARI-RUDMXATFSA-N
|
|||||
| CAS Number |
CAS 483-60-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 320.3 | Topological Polar Surface Area | 93.1 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:168396
|
|||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [2] | |
| OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [3] | ||
| References | ||||||
| 1 | Mycophenolic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. Pharmacogenomics. 2007 Sep;8(9):1127-41. | |||||
| 3 | Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3. Biochem Pharmacol. 2007 Jun 30;74(1):161-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.